Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 10, 1997, Pages 2004-2009

  Mark Herman, S ^a   Robinson, Jacqui T C ^a,b   McCredie, Robyn J ^a,b   Adams, Mark R ^a   Boyer, Michael J ^a   Celermajer, David S ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b HEART RESEARCH INSTITUTE   (Australia)

Author keywords

Atherosclerosis; Endothelium; Nitric oxide; Testosterone

Indexed keywords

ANDROGEN; TESTOSTERONE;

ADULT; AGED; ARTICLE; ATHEROGENESIS; BLOOD VESSEL TONE; CLINICAL ARTICLE; HORMONAL REGULATION; HORMONE INHIBITION; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; TESTOSTERONE BLOOD LEVEL; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 17344372118     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.atv.17.10.2004     Document Type: Article

References (16)

1. Wingard DL. The sex differential in mortality rates. Am J Epidemiol. 1982;205-216.
2. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow up of the Framingham Study. Am Heart J. 1986;111:383-390.
3. Colditz GA, Willet WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
4. Henderson BE, Paganini-Hill A, Ross RK. Estrogen replacement therapy and protection from acute myocardial infarction. Am J Obstet Gynecol. 1988;159:312-317.
5. Haarbo J, Hansen BF, Christiansen C. Hormone replacement therapy prevents coronary artery disease in ovariectomised cholesterol-fed rabbits. APMIS. 1991;99:721-727.
6. Williams JK, Honore EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 1994;24:1757-1761.
7. The Writing Group for the PEPI Trial. Effects of estrogen/progestin regimens on heart disease risk factors in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273:199-208.
8. Kushwaha RS. Female sex steroid hormones and lipoprotein metabolism. Curr Opin Lipidol. 1992;3:167-172.
9. Reis SE, Gloth ST, Blumenthal RA, Resar JR, Gerstenblith G, Brinker JA. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 1994;89:52-60.
10. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA. Estrogen improves endothelial-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-941.
11. Gilligan DM, Quyyumi AA, Cannon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation. 1994;89:2545-2551.
12. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
13. Jiang CW, Sarrel PM, Lindsay PC, Poole-Wilson PA, Collins P. Endothelium independent relaxation of rabbit coronary artery by 17 beta-oestradiol in vitro. Br J Pharmacol. 1991;104:1033-1037.
14. Adams MR, Williams JK, Kaplan JR. Effects of androgens on coronary artery atherosclerosis and atherosclerosis-related impairment of vascular responsiveness. Arterioscler Thromb Vasc Biol. 1995;15:562-570.
15. Hutchison SJ, Sievers RE, Zhu BQ, Sun YP, Sudhir K, Deedwania PC, Parmley WW, Chatterjee K. Physiological concentrations of testosterone impair endothelium-dependent vasorelaxation in hypercholesterolaemic rabbits exposed to tobacco smoke. Abstract. Circulation. 1995;92(suppl I):I-68.
16. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-400.